theory < therapeutic < therapeutics

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by therapeutic

Number of relevant bibliographic references: 102.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000027 (2020)		[Standardized management guideline for pediatric wards of hematology and oncology during the epidemic of coronavirus disease 2019].
000049 (2020)	B. Du [République populaire de Chine] ; H B Qiu [République populaire de Chine] ; X. Zhan [République populaire de Chine] ; Y S Wang [République populaire de Chine] ; H Y J. Kang [République populaire de Chine] ; X Y Li [République populaire de Chine] ; F. Wang [République populaire de Chine] ; B. Sun [République populaire de Chine] ; Z H Tong [République populaire de Chine]	[Pharmacotherapeutics for the New Coronavirus Pneumonia].
000057 (2020)	Kaijin Xu [République populaire de Chine] ; Hongliu Cai [République populaire de Chine] ; Yihong Shen [République populaire de Chine] ; Qin Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Shaohua Hu [République populaire de Chine] ; Jianping Li [République populaire de Chine] ; Huafen Wang [République populaire de Chine] ; Liang Yu [République populaire de Chine] ; He Huang [République populaire de Chine] ; Yunqing Qiu [République populaire de Chine] ; Guoqing Wei [République populaire de Chine] ; Qiang Fang [République populaire de Chine] ; Jianying Zhou [République populaire de Chine] ; Jifang Sheng [République populaire de Chine] ; Tingbo Liang [République populaire de Chine] ; Lanjuan Li [République populaire de Chine]	[Management of corona virus disease-19 (COVID-19): the Zhejiang experience].
000067 (2020)	B L Liu [République populaire de Chine] ; F. Ma ; J N Wang ; Y. Fan ; H N Mo ; B H Xu	[Health management of breast cancer patients outside the hospital during the outbreak of 2019 novel coronavirus disease].
000095 (2020)	L. Yang [République populaire de Chine] ; H Y Xu [République populaire de Chine] ; Y. Wang [République populaire de Chine]	[Diagnostic and therapeutic strategies of lung cancer patients during the outbreak of 2019 novel coronavirus disease (COVID-19)].
000136 (2020)	J. Wang [République populaire de Chine] ; B J Wang [République populaire de Chine] ; J C Yang [République populaire de Chine] ; M Y Wang [République populaire de Chine] ; C. Chen [République populaire de Chine] ; G X Luo [République populaire de Chine] ; W F He [République populaire de Chine]	[Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures].
000204 (2020)	Yaqing Fang [République populaire de Chine] ; Yiting Nie [République populaire de Chine] ; Marshare Penny [États-Unis]	Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis.
000220 (2020)	Robert L. Kruse [États-Unis]	Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China.
000221 (2020)	Phulen Sarma ; Manisha Prajapat ; Pramod Avti ; Hardeep Kaur ; Subodh Kumar ; Bikash Medhi	Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
000222 (2020)	Guangdi Li ; Erik De Clercq	Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
000232 (2020)	Jrhau Lung [Taïwan] ; Yu-Shih Lin [Taïwan] ; Yao-Hsu Yang [Taïwan] ; Yu-Lun Chou [Taïwan] ; Li-Hsin Shu [Taïwan] ; Yu-Ching Cheng [Taïwan] ; Hung Te Liu [Taïwan] ; Ching-Yuan Wu [Taïwan]	The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.
000264 (2020)	Jin-Yan Li [République populaire de Chine] ; Zhi You [République populaire de Chine] ; Qiong Wang [République populaire de Chine] ; Zhi-Jian Zhou [République populaire de Chine] ; Ye Qiu [République populaire de Chine] ; Rui Luo [République populaire de Chine] ; Xing-Yi Ge [République populaire de Chine]	The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.
000266 (2020)	Suliman Khan [République populaire de Chine] ; Rabeea Siddique [République populaire de Chine] ; Muhammad Adnan Shereen [République populaire de Chine] ; Ashaq Ali [République populaire de Chine] ; Jianbo Liu ; Qian Bai [République populaire de Chine] ; Nadia Bashir [République populaire de Chine] ; Mengzhou Xue [République populaire de Chine]	The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options.
000307 (2020)	Sophie Alexandra Baron [France] ; Christian Devaux [France] ; Philippe Colson [France] ; Didier Raoult [France] ; Jean-Marc Rolain [France]	Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19?
000315 (2020)	Lan Zhu [République populaire de Chine] ; Xizhen Xu [République populaire de Chine] ; Ke Ma [République populaire de Chine] ; Junling Yang [République populaire de Chine] ; Hanxiong Guan [République populaire de Chine] ; Song Chen [République populaire de Chine] ; Zhishui Chen [République populaire de Chine] ; Gang Chen [République populaire de Chine]	Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.
000373 (2020)	Markus Hoffmann [Allemagne] ; Hannah Kleine-Weber [Allemagne] ; Simon Schroeder [Allemagne] ; Nadine Krüger [Allemagne] ; Tanja Herrler [Allemagne] ; Sandra Erichsen [Autriche] ; Tobias S. Schiergens [Allemagne] ; Georg Herrler [Allemagne] ; Nai-Huei Wu [Allemagne] ; Andreas Nitsche [Allemagne] ; Marcel A. Müller [Russie] ; Christian Drosten [Allemagne] ; Stefan Pöhlmann [Allemagne]	SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
000401 (2020)	Jaffar A. Al-Tawfiq [États-Unis] ; Ali H. Al-Homoud [Arabie saoudite] ; Ziad A. Memish [États-Unis]	Remdesivir as a possible therapeutic option for the COVID-19.
000488 (2020)	Xiaolong Tian [République populaire de Chine] ; Cheng Li [République populaire de Chine] ; Ailing Huang [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Sicong Lu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Lu Lu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Zhenlin Yang [République populaire de Chine] ; Yanling Wu [République populaire de Chine] ; Tianlei Ying [République populaire de Chine]	Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.
000490 (2020)	Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie]	Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
000503 (2020)	Kollengode Ramanathan [Australie] ; David Antognini [Australie] ; Alain Combes [France] ; Matthew Paden [États-Unis] ; Bishoy Zakhary [États-Unis] ; Mark Ogino [États-Unis] ; Graeme Maclaren [Australie] ; Daniel Brodie [États-Unis] ; Kiran Shekar [Australie]	Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.
000506 (2020)	Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande]	Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "therapeutic" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "therapeutic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    therapeutic
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021